Preparing for a Tsunami of Public Health Challenges

by The Honorable Jim Greenwood Biopharmaceutical companies are at the forefront of expanding our understanding of the genetic and biomolecular basis of disease, and their researchers are committed to developing the next generation of modern medicines. However, this goal can be realized only in an environment of forward-looking public policies that sustain scientific discovery and […]

The Right Target at the Right Time in Alzheimer’s Disease

by Reisa Sperling For so many years now, the focus of Alzheimer’s disease (AD) research has been on trying (and failing) to manage Alzheimer’s symptoms at later stages of the disease, rather than preventing these devastating symptoms from developing in the first place. And over the past ten years or so, as we are painfully […]